Mesothelioma Treatment in New York

Treatment Options and Resources for Mesothelioma in New York

Mesothelioma patients residing in New York can access a comprehensive array of advanced treatments and vital support services. This guide aims to delve deeper into mesothelioma statistics, leading cancer centers, distinguished medical professionals, ongoing clinical trials, and indispensable support services available within the state.

Mesothelioma Cancer Centers in New York

New York proudly hosts several distinguished cancer centers that specialize in mesothelioma treatment. These centers offer not only state-of-the-art care but also access to innovative therapies. Below are some notable options:

  • Albert Einstein Cancer Center (Bronx, NY 10461)
  • Hematology and Oncology Associates of Central New York (East Syracuse, NY 13057)
  • Herbert Irving Comprehensive Cancer Center (New York, NY 10032)
  • Mount Sinai Medical Center (New York, NY 10029)
  • NY-Presbyterian/Columbia University Medical Center (New York, NY 10032)
  • NYU Langone Medical Center (New York, NY 10016)
  • Roswell Park Comprehensive Cancer Center (Buffalo, NY 14203)
  • University of Rochester Medical Center (Rochester, NY 14642)

These centers house dedicated teams of experts who are committed to delivering personalized and comprehensive mesothelioma treatment plans.

Mesothelioma Doctors in New York

New York boasts a roster of accomplished mesothelioma doctors, each contributing significantly to the advancement of mesothelioma treatment. Here are some standout specialists:

  • John D. Allendorf, M.D. – Surgical Oncologist (Patchogue, NY)
  • Shahriyour Andaz, M.D. – Director of Thoracic Oncology (Lynbrook, NY)
  • Robert J. Cerfolio, M.D. – Specialist in Thoracic Surgery, Head of Clinical Thoracic Surgery, and Director of the Lung Cancer Center at NYU Langone (New York, NY)
  • John A. Chabot, M.D. – Chief of the Division of GI & Endocrine Surgery and Executive Director of the Pancreas Center (New York, NY)
  • Cliff P. Connery, M.D. – Cardiothoracic Surgeon (Poughkeepsie, NY)
  • Raja M. Flores, M.D. – Chair of the Department of Thoracic Surgery (New York, NY)
  • Giuseppe Giaccone, M.D. – Chief of Thoracic Oncology (New York, NY)
  • Daniel M. Labow, M.D. – Surgical Oncologist (New York, NY)
  • Harvey Pass, M.D. – Director of General Thoracic Surgery and Chief of Thoracic Oncology (New York, NY)
  • Roman Perez-Soler, M.D. – Chief of the Division of Medical Oncology (Bronx, NY)
  • Stephen C. Rush, M.D. – Radiation Oncologist (New York, NY)
  • Umut Sarpel, M.D. – Surgical Oncologist (New York, NY)
  • Daniel H. Sterman, M.D. – Director of Multidisciplinary Pulmonary Oncology Program (New York, NY)
  • Emanuela Taioli, M.D. – Director of the Institute for Translational Epidemiology and the Center for the Study of Thoracic Diseases Outcomes (New York, NY)
  • Tracey L. Weigel, M.D. – Chief of Thoracic Surgery (Valhalla, NY)
  • Andrea S. Wolf, M.D. – Thoracic Surgeon (New York, NY)
  • Sai Yendamuri, M.D. – Director of the Thoracic Surgery Laboratory (Buffalo, NY)

These experts are renowned for their dedication to providing tailored care and pushing the boundaries of mesothelioma treatment.

Ongoing Clinical Trials in New York

Clinical trials offer new hope for mesothelioma patients. Several ongoing trials in New York are exploring innovative approaches to treatment:

  1. Integrated Cancer Repository for Cancer Research (iCaRe2): Investigating various cancer types, including mesothelioma. (Recruiting)
  2. DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma (DREAM3R): Assessing a combination therapy for mesothelioma. (Recruiting)
  3. Testing the Addition of Targeted Radiation Therapy to Surgery and Chemotherapy for Malignant Pleural Mesothelioma: Evaluating the role of radiation therapy. (Recruiting)
  4. Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas: Exploring a novel treatment approach. (Recruiting)
  5. Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53: Investigating a potential therapy for various solid tumors. (Recruiting)

Participating in clinical trials can provide patients with access to groundbreaking treatments and contribute to the advancement of mesothelioma research.

Support Services for Mesothelioma Patients

Prioritizing the physical and emotional welfare of mesothelioma patients is of utmost importance. In New York, a wide range of support services is accessible, encompassing cancer rehabilitation, counseling, extended lodging options, the provision of oxygen, and assistance with patient transportation.